5P5J
| |
5P1L
| |
5P20
| |
5P2G
| |
1I09
| |
1WVN
| |
3FDN
| Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity | Descriptor: | N-[3-(acetylamino)phenyl]-5-{(2E)-2-[(4-methoxyphenyl)methylidene]hydrazino}-3-methyl-1H-pyrazole-4-carboxamide, Serine/threonine-protein kinase 6 | Authors: | Leou, J.S, Wu, J.S, Coumar, M.S, Shukla, P, Hsieh, H.P, Wu, S.Y. | Deposit date: | 2008-11-26 | Release date: | 2009-09-15 | Last modified: | 2023-11-01 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Structure-based drug design of novel Aurora kinase A inhibitors: structural basis for potency and specificity J.Med.Chem., 52, 2009
|
|
3TZM
| TGF-beta Receptor type 1 in complex with SB431542 | Descriptor: | 4-[5-(1,3-benzodioxol-5-yl)-4-(pyridin-2-yl)-1H-imidazol-2-yl]benzamide, TGF-beta receptor type-1 | Authors: | Ogunjimi, A.A, Zeqiraj, E, Ceccarelli, D.F, Sicheri, F. | Deposit date: | 2011-09-27 | Release date: | 2012-05-23 | Last modified: | 2023-09-13 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | Structural Basis for Specificity of TGFbeta Family Receptor Small Molecule Inhibitors Cell Signal, 24, 2012
|
|
5P2U
| |
5P39
| |
5P3M
| |
5OZQ
| |
5P41
| |
5P01
| |
2D09
| |
1WWG
| NMR Structure Determined for MLV NC Complex with RNA Sequence UAUCUG | Descriptor: | 5'-R(P*UP*AP*UP*CP*UP*G)-3', Nucleoprotein p10, ZINC ION | Authors: | Dey, A, York, D, Smalls-Mantey, A, Summers, M.F. | Deposit date: | 2005-01-05 | Release date: | 2005-04-05 | Last modified: | 2024-05-29 | Method: | SOLUTION NMR | Cite: | Composition and sequence-dependent binding of RNA to the nucleocapsid protein of Moloney murine leukemia virus(,) Biochemistry, 44, 2005
|
|
5P4M
| |
5P52
| |
5P0E
| |
5P5F
| |
5P0S
| |
5P5U
| |
2CUE
| Solution structure of the homeobox domain of the human paired box protein Pax-6 | Descriptor: | Paired box protein Pax6 | Authors: | Ohnishi, S, Kigawa, T, Tochio, N, Tomizawa, T, Koshiba, S, Inoue, M, Yokoyama, S, RIKEN Structural Genomics/Proteomics Initiative (RSGI) | Deposit date: | 2005-05-26 | Release date: | 2005-11-26 | Last modified: | 2024-05-29 | Method: | SOLUTION NMR | Cite: | Solution structure of the homeobox domain of the human paired box protein Pax-6 To be Published
|
|
1SQO
| Substituted 2-Naphthamidine Inhibitors of Urokinase | Descriptor: | 8-(PYRIMIDIN-2-YLAMINO)NAPHTHALENE-2-CARBOXIMIDAMIDE, SULFATE ION, Urokinase-type plasminogen activator | Authors: | Wendt, M.D, Geyer, A, McClellan, W.J, Rockway, T.W, Weitzberg, M, Zhao, X, Mantei, R, Stewart, K, Nienaber, V, Klinghofer, V, Giranda, V.L. | Deposit date: | 2004-03-19 | Release date: | 2004-04-27 | Last modified: | 2011-07-13 | Method: | X-RAY DIFFRACTION (1.84 Å) | Cite: | Interaction with the S1beta-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors. Bioorg.Med.Chem.Lett., 14, 2004
|
|
5P18
| |